Joseph Pantginis

Dr. Joseph Pantginis is a Director of Research & Managing Director of Equity Research at H.
C.
Wainwright & Co. LLC.
He has over 17 years of experience in healthcare equity research.
Prior to joining Rodman & Renshaw, Dr. Pantginis was most recently Senior Research Analyst and Head of Biotechnology Research at ROTH Capital Partners.
Prior positions included senior positions at Merriman, Canaccord Adams, Commerce Capital Markets, JBHanauer and Ladenburg.
Prior to his equity research career, he worked at Regeneron Pharmaceuticals, where he founded the Retroviral Core Facility.
Dr. Pantginis earned a Ph.D.
and M.S.
in molecular genetics from the Albert Einstein College of Medicine as well as an M.B.A. from Pace University.